Emerging Frontiers in Therapeutics of Diffuse Large B Cell Lymphoma: Epigenetics and B Cell Receptor Signaling
Soham Puvvada, Lisa Rimsza

J. Cancer Ther. Vol.4 No.3 A, March 25, 2013
DOI:10.4236/jct.2013.43A059

Cell Origin Subtypes Predict Outcomes in Localized-Stage Diffuse Large B-Cell Lymphoma Treated with Curative Radiotherapy
Yuko Watanabe, Hiroaki Suefuji, Etsuyo Ogo, Kensaku Sato, Tadashi Nakashima, Takashi Okamura, Koichi Ohshima, Naofumi Hayabuchi

J. Cancer Ther. Vol.4 No.3 A, March 25, 2013
DOI:10.4236/jct.2013.43A058

MicroRNAs as Targets and Tools in B-Cell Lymphoma Therapy
Kalman Szenthe, Katalin Nagy, Krisztina Buzas, Hans Helmut Niller, Janos Minarovits

J. Cancer Ther. Vol.4 No.3 A, March 25, 2013
DOI:10.4236/jct.2013.43A057

Biological Therapy and Risk of Malignancies: A Literature Review
Gilda Sandri, Valentina Cestelli, Maria Teresa Mascia

J. Cancer Ther. Vol.4 No.3 A, March 18, 2013
DOI:10.4236/jct.2013.43A056

Absolute Lymphocyte/Monocyte Ratio at Diagnosis and Interim Positron-Emission Tomography Predict Survival in Classical Hodgkin Lymphoma
Luis F. Porrata, Kay M. Ristow, Thomas M. Habermann, Thomas E. Witzig, Joseph P. Colgan, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Grzegorz Nowakowski, Carrie A. Thompson, Svetomir N. Markovic

J. Cancer Ther. Vol.4 No.3 A, March 07, 2013
DOI:10.4236/jct.2013.43A055